Last reviewed · How we verify
Ginkgo leaf dropping pill — Competitive Intelligence Brief
marketed
Herbal extract / Traditional medicine
Neurology / Cognitive disorders
Small molecule
Live · refreshed every 30 min
Target snapshot
Ginkgo leaf dropping pill (Ginkgo leaf dropping pill) — Wanbangde Pharmaceutical Group Co., LTD. Ginkgo leaf extract improves blood circulation and reduces blood viscosity to enhance cerebral blood flow and oxygen delivery.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ginkgo leaf dropping pill TARGET | Ginkgo leaf dropping pill | Wanbangde Pharmaceutical Group Co., LTD | marketed | Herbal extract / Traditional medicine |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Herbal extract / Traditional medicine class)
- Wanbangde Pharmaceutical Group Co., LTD · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ginkgo leaf dropping pill CI watch — RSS
- Ginkgo leaf dropping pill CI watch — Atom
- Ginkgo leaf dropping pill CI watch — JSON
- Ginkgo leaf dropping pill alone — RSS
- Whole Herbal extract / Traditional medicine class — RSS
Cite this brief
Drug Landscape (2026). Ginkgo leaf dropping pill — Competitive Intelligence Brief. https://druglandscape.com/ci/ginkgo-leaf-dropping-pill. Accessed 2026-06-09.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing